ProVerum Medical is a medtech company that develops novel minimally invasive devices to treat benign prostatic hyperplasia.
ProVerum Medical has raised $80.0M in total funding. The most recent round was Series B. The last funding was announced in August 2025.
ProVerum Medical's investors include OrbiMed, Lightstone Ventures, Enterprise Ireland, MVM Life Science Partners, Ireland Strategic Investment Fund.
ProVerum Medical is headquartered in Dublin, Ireland.
ProVerum Medical is a medtech company that develops novel minimally invasive devices to treat benign prostatic hyperplasia.
ProVerum Medical is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ProVerum Medical — Funding & Investors." VCBacked, August 25, 2025, https://www.vcbacked.co/company/proverum-medical. Accessed July 19, 2026.
VCBacked. (2025). ProVerum Medical — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/proverum-medical
{{cite web |title=ProVerum Medical — Funding & Investors |url=https://www.vcbacked.co/company/proverum-medical |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated